Remission induction in early rheumatoid arthritis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON20139

Enrollment

200

Registered

2006-01-12

Start date

2006-01-09

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observational study.

Interventions

Tight control of disease activity by a strict treatment scheme and strictly defined decision moments for treatment changes.

Eligibility

Inclusion criteria

Inclusion criteria: 1. RA according to ACR1987 criteria; 2. diagnosis RA 18; 4. no prior DMARD use; 5. DAS 28 > 3.2 and/or erosions.

Exclusion criteria

Exclusion criteria: Pregnancy/pregnancy wish.

Design outcomes

Primary

Measure	Time frame
Percentage of patients reaching DAS28<2.6.	—

Secondary

Measure	Time frame
1. Radiographic changes; 2. Percentage of patients staying in remission; 3. Percentage of patients staying in remission after discontinuation of anti-YNF medication.	—

Contacts

Public ContactH.H. Kuper

Medisch Spectrum Twente

h.kuper@ziekenhuis-mst.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)